These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30461299)

  • 1. Turned Inside Out: Will Myelin-Protective Therapies Become the Next-Generation Anti-Inflammatories?
    Caprariello AV; Stys PK
    DNA Cell Biol; 2019 Mar; 38(3):219-222. PubMed ID: 30461299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemically altered myelin triggers autoimmune demyelination.
    Caprariello AV; Rogers JA; Morgan ML; Hoghooghi V; Plemel JR; Koebel A; Tsutsui S; Dunn JF; Kotra LP; Ousman SS; Wee Yong V; Stys PK
    Proc Natl Acad Sci U S A; 2018 May; 115(21):5528-5533. PubMed ID: 29728463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of autoimmunity in multiple sclerosis.
    Whitaker JN; Snyder DS
    CRC Crit Rev Clin Neurobiol; 1984; 1(1):45-82. PubMed ID: 6400508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of myelin oligodendrocyte glycoprotein in autoimmune demyelination: a target for multiple sclerosis therapy?
    Lee DH; Linker RA
    Expert Opin Ther Targets; 2012 May; 16(5):451-62. PubMed ID: 22494461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spreading of autoimmunity from central to peripheral myelin: two cases of clinical association between multiple sclerosis and chronic inflammatory demyelinating polyneuropathy.
    Falcone M; Scalise A; Minisci C; Romito D; Cancelli I; Gigli GL
    Neurol Sci; 2006 Apr; 27(1):58-62. PubMed ID: 16688601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecules affecting myelin stability: a novel hypothesis regarding the pathogenesis of multiple sclerosis.
    Mastronardi FG; Moscarello MA
    J Neurosci Res; 2005 May; 80(3):301-8. PubMed ID: 15704220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance is futile: antineuronal autoimmunity in multiple sclerosis.
    Huizinga R; Linington C; Amor S
    Trends Immunol; 2008 Feb; 29(2):54-60. PubMed ID: 18182323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Autoimmunity and nervous diseases].
    Lehoczky T
    Munch Med Wochenschr; 1966 Aug; 108(31):1518-22 passim. PubMed ID: 4169913
    [No Abstract]   [Full Text] [Related]  

  • 9. Multiple sclerosis: immunopathologic mechanisms in the progression and resolution of inflammatory demyelination.
    Raine CS
    Res Publ Assoc Res Nerv Ment Dis; 1990; 68():37-54. PubMed ID: 1691521
    [No Abstract]   [Full Text] [Related]  

  • 10. Autoreactive T lymphocytes in multiple sclerosis: pathogenic role and therapeutic targeting.
    Stinissen P; Raus J
    Acta Neurol Belg; 1999 Mar; 99(1):65-9. PubMed ID: 10218096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demyelination in multiple sclerosis.
    Lubetzki C; Stankoff B
    Handb Clin Neurol; 2014; 122():89-99. PubMed ID: 24507514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deleterious versus protective autoimmunity in multiple sclerosis.
    Kostic M; Stojanovic I; Marjanovic G; Zivkovic N; Cvetanovic A
    Cell Immunol; 2015 Aug; 296(2):122-32. PubMed ID: 25944389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular and molecular mechanisms of autoimmune demyelination in the central nervous system.
    Glynn P; Linington C
    Crit Rev Neurobiol; 1989; 4(4):367-85. PubMed ID: 2655941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targets of the humoral autoimmune response in multiple sclerosis.
    Fraussen J; Claes N; de Bock L; Somers V
    Autoimmun Rev; 2014 Nov; 13(11):1126-37. PubMed ID: 25108168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid cause demyelination of spinal cord explants.
    Blauth K; Soltys J; Matschulat A; Reiter CR; Ritchie A; Baird NL; Bennett JL; Owens GP
    Acta Neuropathol; 2015 Dec; 130(6):765-81. PubMed ID: 26511623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple sclerosis: an immune or neurodegenerative disorder?
    Trapp BD; Nave KA
    Annu Rev Neurosci; 2008; 31():247-69. PubMed ID: 18558855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular "negativity" may underlie multiple sclerosis: role of the myelin basic protein family in the pathogenesis of MS.
    Musse AA; Harauz G
    Int Rev Neurobiol; 2007; 79():149-72. PubMed ID: 17531841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myelin reactive T cells in the autoimmune pathogenesis of multiple sclerosis.
    Stinissen P; Medaer R; Raus J
    Mult Scler; 1998 Jun; 4(3):203-11. PubMed ID: 9762675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interaction of central nervous system local immunity and systemic immunity during multiple sclerosis].
    Tourtellotte WW
    Rev Neurol (Paris); 1972 Nov; 127(5):497-504. PubMed ID: 4588993
    [No Abstract]   [Full Text] [Related]  

  • 20. Insights into the immunopathogenesis of multiple sclerosis.
    Hellings N; Raus J; Stinissen P
    Immunol Res; 2002; 25(1):27-51. PubMed ID: 11868933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.